Increased shear stress- and ristocetin-induced binding of von Willebrand factor to platelets in cord compared with adult plasma. 2004

Thomas Rehak, and Gerhard Cvirn, and Siegfried Gallistl, and Bettina Leschnik, and Martin Köstenberger, and Helga Katzer, and Volker Ribitsch, and Wolfgang Muntean
Ludwig Boltzmann Research Institute for Pediatric Hemostasis and Thrombosis, Graz, Austria.

Multiple indications do exist that the extensive neonatal platelet adhesion and aggregation, and the shorter closure time of neonatal compared with adult whole blood in the platelet function analyzer 100 are attributable to the physiological high plasma concentrations and high concentrations of unusually large von Willebrand factor (vWf) multimers in neonates. However, to date the direct experimental evidence is lacking. Therefore, we compared in the present study the ability of neonatal vWf to bind to platelets to that of adult vWf. Platelet-poor plasma of neonatal or adult origin, containing antibody-stained vWf, was incubated with neonatal or adult platelet suspension. Subsequently, vWf-platelet interaction was induced by exposing the mixture to shear stress by means of a cone/plate measuring system or by incubating the mixture with ristocetin. Finally, samples were analyzed in a FACScan flow cytometer. Detected fluorescence intensities directly correlate with the amount of vWf attached to the platelet surface. We found that significantly higher amounts of neonatal vWf were attached to platelets in the presence of shear stress or ristocetin. This efficient neonatal vWf-platelet interaction is an effect intrinsic to the neonatal vWf, and not to the neonatal platelet: the amount of neonatal vWf attached to neonatal platelets was not different from the amount of neonatal vWf attached to adult platelets. Furthermore, decreasing the vWf content in cord plasma to adult level resulted in significantly suppressed vWf-platelet attachment in the presence of ristocetin, indicating that the high neonatal vWf level contributes to the efficient vWf-platelet binding in neonates.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D010979 Platelet Function Tests Laboratory examination used to monitor and evaluate platelet function in a patient's blood. Function Test, Platelet,Function Tests, Platelet,Platelet Function Test,Test, Platelet Function,Tests, Platelet Function
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D001773 Blood Cells The cells found in the body fluid circulating throughout the CARDIOVASCULAR SYSTEM. Blood Corpuscles,Blood Cell,Blood Corpuscle,Cell, Blood,Cells, Blood,Corpuscle, Blood,Corpuscles, Blood
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D005312 Fetal Blood Blood of the fetus. Exchange of nutrients and waste between the fetal and maternal blood occurs via the PLACENTA. The cord blood is blood contained in the umbilical vessels (UMBILICAL CORD) at the time of delivery. Cord Blood,Umbilical Cord Blood,Blood, Cord,Blood, Fetal,Blood, Umbilical Cord,Bloods, Cord,Bloods, Fetal,Bloods, Umbilical Cord,Cord Blood, Umbilical,Cord Bloods,Cord Bloods, Umbilical,Fetal Bloods,Umbilical Cord Bloods
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012310 Ristocetin An antibiotic mixture of two components, A and B, obtained from Nocardia lurida (or the same substance produced by any other means). It is no longer used clinically because of its toxicity. It causes platelet agglutination and blood coagulation and is used to assay those functions in vitro. Ristomycin

Related Publications

Thomas Rehak, and Gerhard Cvirn, and Siegfried Gallistl, and Bettina Leschnik, and Martin Köstenberger, and Helga Katzer, and Volker Ribitsch, and Wolfgang Muntean
January 1997, Biorheology,
Thomas Rehak, and Gerhard Cvirn, and Siegfried Gallistl, and Bettina Leschnik, and Martin Köstenberger, and Helga Katzer, and Volker Ribitsch, and Wolfgang Muntean
January 1980, Thrombosis research,
Thomas Rehak, and Gerhard Cvirn, and Siegfried Gallistl, and Bettina Leschnik, and Martin Köstenberger, and Helga Katzer, and Volker Ribitsch, and Wolfgang Muntean
November 2000, Thrombosis research,
Thomas Rehak, and Gerhard Cvirn, and Siegfried Gallistl, and Bettina Leschnik, and Martin Köstenberger, and Helga Katzer, and Volker Ribitsch, and Wolfgang Muntean
September 1994, The Biochemical journal,
Thomas Rehak, and Gerhard Cvirn, and Siegfried Gallistl, and Bettina Leschnik, and Martin Köstenberger, and Helga Katzer, and Volker Ribitsch, and Wolfgang Muntean
June 1982, Thrombosis research,
Thomas Rehak, and Gerhard Cvirn, and Siegfried Gallistl, and Bettina Leschnik, and Martin Köstenberger, and Helga Katzer, and Volker Ribitsch, and Wolfgang Muntean
August 1997, Thrombosis and haemostasis,
Thomas Rehak, and Gerhard Cvirn, and Siegfried Gallistl, and Bettina Leschnik, and Martin Köstenberger, and Helga Katzer, and Volker Ribitsch, and Wolfgang Muntean
October 2007, Cardiovascular & hematological agents in medicinal chemistry,
Thomas Rehak, and Gerhard Cvirn, and Siegfried Gallistl, and Bettina Leschnik, and Martin Köstenberger, and Helga Katzer, and Volker Ribitsch, and Wolfgang Muntean
July 1980, The Journal of laboratory and clinical medicine,
Thomas Rehak, and Gerhard Cvirn, and Siegfried Gallistl, and Bettina Leschnik, and Martin Köstenberger, and Helga Katzer, and Volker Ribitsch, and Wolfgang Muntean
July 2016, Artificial organs,
Thomas Rehak, and Gerhard Cvirn, and Siegfried Gallistl, and Bettina Leschnik, and Martin Köstenberger, and Helga Katzer, and Volker Ribitsch, and Wolfgang Muntean
November 2010, European biophysics journal : EBJ,
Copied contents to your clipboard!